203 related articles for article (PubMed ID: 21855698)
1. Obesity and dyslipidemia.
Franssen R; Monajemi H; Stroes ES; Kastelein JJ
Med Clin North Am; 2011 Sep; 95(5):893-902. PubMed ID: 21855698
[TBL] [Abstract][Full Text] [Related]
2. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
3. [Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)].
Farnier M
Arch Mal Coeur Vaiss; 2007 Dec; 100(12):979-84. PubMed ID: 18223510
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.
Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995
[TBL] [Abstract][Full Text] [Related]
5. Abdominal obesity and metabolic syndrome.
Després JP; Lemieux I
Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
[TBL] [Abstract][Full Text] [Related]
6. Impact of obesity on cardiovascular disease.
Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
[TBL] [Abstract][Full Text] [Related]
7. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events.
Zarich SW
Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
10. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
11. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease.
Meshkani R; Adeli K
Clin Biochem; 2009 Sep; 42(13-14):1331-46. PubMed ID: 19501581
[TBL] [Abstract][Full Text] [Related]
12. Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome.
Kawai T; Ito T; Ohwada K; Mera Y; Matsushita M; Tomoike H
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2752-7. PubMed ID: 16990556
[TBL] [Abstract][Full Text] [Related]
13. Diet-induced central obesity and insulin resistance in rabbits.
Zhao S; Chu Y; Zhang C; Lin Y; Xu K; Yang P; Fan J; Liu E
J Anim Physiol Anim Nutr (Berl); 2008 Feb; 92(1):105-11. PubMed ID: 18184386
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models.
den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and the metabolic syndrome.
Weerakiet S
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
Smith AG; Muscat GE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
[TBL] [Abstract][Full Text] [Related]
17. Relationship between lipid abnormalities and insulin resistance in Japanese school children.
Asato Y; Katsuren K; Ohshiro T; Kikawa K; Shimabukuro T; Ohta T
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2781-6. PubMed ID: 16990559
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in young people.
Poyrazoglu S; Bas F; Darendeliler F
Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
[TBL] [Abstract][Full Text] [Related]
19. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
Adiels M; Olofsson SO; Taskinen MR; Borén J
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
[TBL] [Abstract][Full Text] [Related]
20. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
